Virpax Pharmaceuticals (VRPX) Q2 2025 Earnings

30MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-9.25
-6.35
-3.44
-0.54

Details

Expected EPS
-5.25
Actual EPS
N/A
Surprise EPS
5.25
Surprise Percent
+100%

Description

Virpax Pharmaceuticals (VRPX) will report earnings of for Q2 2025 on May 30, 2025.

0 Comments

Share your thoughts